Theralase Technologies Inc.
TLTFF
$0.17
$0.014.06%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 16.90% | 5.52% | 2.51% | 6.06% | 2.68% |
| Total Depreciation and Amortization | -3.20% | -4.28% | -7.65% | -8.25% | -7.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -10.01% | 7.71% | 29.49% | 8.85% | -14.28% |
| Change in Net Operating Assets | -125.84% | -131.95% | 244.40% | -49.68% | 280.56% |
| Cash from Operations | -21.32% | 3.70% | 39.63% | 5.33% | 37.06% |
| Capital Expenditure | 118.49% | -133.79% | -283.33% | -224.75% | -164.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 120.95% | -133.79% | -283.33% | -224.75% | -164.19% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.96% | -2.47% | 12.32% | 15.97% | 20.22% |
| Issuance of Common Stock | 34.08% | -19.35% | -44.81% | -13.30% | -29.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 0.00% | -- | -- | -- |
| Cash from Financing | 47.97% | -11.24% | -44.73% | -14.92% | -30.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,382.78% | -135.59% | -355.46% | -2,234.38% | 109.69% |